Home
>
National Drug Code (NDC)
>
Lipitor
Lipitor - 0071-0155-23 - (ATORVASTATIN CALCIUM)
Drug Information of Lipitor
| Product NDC: | 0071-0155 |
| Proprietary Name: | Lipitor |
| Non Proprietary Name: | ATORVASTATIN CALCIUM |
| Active Ingredient(s): | 10 mg/1 & nbsp; ATORVASTATIN CALCIUM |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Lipitor
| Product NDC: | 0071-0155 |
| Labeler Name: | Parke-Davis Div of Pfizer Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020702 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19961217 |
Package Information of Lipitor
| Package NDC: | 0071-0155-23 |
| Package Description: | 90 TABLET, FILM COATED in 1 BOTTLE (0071-0155-23) |
NDC Information of Lipitor
| NDC Code | 0071-0155-23 |
| Proprietary Name | Lipitor |
| Package Description | 90 TABLET, FILM COATED in 1 BOTTLE (0071-0155-23) |
| Product NDC | 0071-0155 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ATORVASTATIN CALCIUM |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 19961217 |
| Marketing Category Name | NDA |
| Labeler Name | Parke-Davis Div of Pfizer Inc |
| Substance Name | ATORVASTATIN CALCIUM |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |
